Edition:
United Kingdom

TherapeuticsMD Inc (TXMD.OQ)

TXMD.OQ on NASDAQ Stock Exchange Global Select Market

5.58USD
16 Feb 2018
Change (% chg)

$0.06 (+1.09%)
Prev Close
$5.52
Open
$5.49
Day's High
$5.61
Day's Low
$5.46
Volume
413,179
Avg. Vol
649,632
52-wk High
$8.29
52-wk Low
$3.50

Chart for

About

TherapeuticsMD, Inc. is a women's healthcare company engaged in creating and commercializing products for women. The Company is focused on pursuing regulatory approvals and pre-commercialization activities necessary for commercialization of its hormone therapy pharmaceutical products. Its drug candidates used in clinical trials... (more)

Overall

Beta: 0.95
Market Cap(Mil.): $1,082.14
Shares Outstanding(Mil.): 216.43
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.64
EPS (TTM): -- -- --
ROI: -- 14.90 10.66
ROE: -- 16.41 14.30

BRIEF-TherapeuticsMD Submits New Drug Application For TX-001HR

* THERAPEUTICSMD ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION FOR TX-001HR

28 Dec 2017

BRIEF-Therapeuticsmd Announces FDA Acceptance Of New Drug Application And PDUFA Date For TX-004HR

* THERAPEUTICSMD ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION AND PRESCRIPTION DRUG USER FEE ACT (PDUFA) DATE FOR TX-004HR

19 Dec 2017

BRIEF-TherapeuticsMD reports Q3 loss per share of $0.07

* TherapeuticsMD announces third quarter 2017 financial results

06 Nov 2017

BRIEF-TherapeuticsMD announces plan to resubmit the new drug application for TX-004HR

* TherapeuticsMD Inc announces plan to resubmit the new drug application for TX-004HR

06 Nov 2017

Earnings vs. Estimates